Biomarker identification in breast cancer : Beta-adrenergic receptor signaling and pathways to therapeutic response
Recent preclinical studies have associated beta-adrenergic receptor (β-AR) signaling with breast cancer pathways such as progression and metastasis. These findings have been supported by clinical and epidemiological studies which examined the effect of beta-blocker therapy on breast cancer metastasis, recurrence and mortality. Results from these studies have provided initial evidence for the inhibition of cell migration in breast cancer by beta-blockers and have introduced the beta-adrenergic receptor pathways as a target for therapy. This paper analyzes gene expression profiles in breast cancer patients, utilising Artificial Neural Networks (ANNs) to identify molecular signatures corresponding to possible disease management pathways and biomarker treatment strategies associated with beta-2-adrenergic receptor (ADRB2) cell signaling. The adrenergic receptor relationship to cancer is investigated in order to validate the results of recent studies that suggest the use of beta-blockers for breast cancer therapy. A panel of genes is identified which has previously been reported to play an important role in cancer and also to be involved in the beta-adrenergic receptor signaling.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2013 |
|---|---|
| Erschienen: |
2013 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:6 |
|---|---|
| Enthalten in: |
Computational and structural biotechnology journal - 6(2013) vom: 01., Seite e201303003 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kafetzopoulou, Liana E [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Artificial Neural Networks |
|---|
| Anmerkungen: |
Date Completed 01.04.2014 Date Revised 21.10.2021 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.5936/csbj.201303003 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM236948466 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM236948466 | ||
| 003 | DE-627 | ||
| 005 | 20231224110628.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.5936/csbj.201303003 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0789.xml |
| 035 | |a (DE-627)NLM236948466 | ||
| 035 | |a (NLM)24688711 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kafetzopoulou, Liana E |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Biomarker identification in breast cancer |b Beta-adrenergic receptor signaling and pathways to therapeutic response |
| 264 | 1 | |c 2013 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.04.2014 | ||
| 500 | |a Date Revised 21.10.2021 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Recent preclinical studies have associated beta-adrenergic receptor (β-AR) signaling with breast cancer pathways such as progression and metastasis. These findings have been supported by clinical and epidemiological studies which examined the effect of beta-blocker therapy on breast cancer metastasis, recurrence and mortality. Results from these studies have provided initial evidence for the inhibition of cell migration in breast cancer by beta-blockers and have introduced the beta-adrenergic receptor pathways as a target for therapy. This paper analyzes gene expression profiles in breast cancer patients, utilising Artificial Neural Networks (ANNs) to identify molecular signatures corresponding to possible disease management pathways and biomarker treatment strategies associated with beta-2-adrenergic receptor (ADRB2) cell signaling. The adrenergic receptor relationship to cancer is investigated in order to validate the results of recent studies that suggest the use of beta-blockers for breast cancer therapy. A panel of genes is identified which has previously been reported to play an important role in cancer and also to be involved in the beta-adrenergic receptor signaling | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Artificial Neural Networks | |
| 650 | 4 | |a Beta-2-Adrenergic Receptor | |
| 650 | 4 | |a Microarray Data | |
| 650 | 4 | |a beta-blockers | |
| 700 | 1 | |a Boocock, David J |e verfasserin |4 aut | |
| 700 | 1 | |a Dhondalay, Gopal Krishna R |e verfasserin |4 aut | |
| 700 | 1 | |a Powe, Desmond G |e verfasserin |4 aut | |
| 700 | 1 | |a Ball, Graham R |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Computational and structural biotechnology journal |d 2012 |g 6(2013) vom: 01., Seite e201303003 |w (DE-627)NLM218960549 |x 2001-0370 |7 nnns |
| 773 | 1 | 8 | |g volume:6 |g year:2013 |g day:01 |g pages:e201303003 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.5936/csbj.201303003 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 6 |j 2013 |b 01 |h e201303003 | ||